BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
News | 03. 20. 2013
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
